Andrew Robb's Insider Trades & SAST Disclosures
Andrew Robb's most recent trade in International Paper Co. was a trade of 1,065 Common Stock done . Disclosure was reported to the exchange on March 6, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Andrew Robb.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| International Paper Co. | David Andrew Robbie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 1,065 | 4,920 (0%) | 0% | 0 | Common Stock | |
| Tamboran Resources Corp. | Andrew Robb | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 2,505 | 4,505 | - | 0 | Common Stock | |
| Cogent Biosciences Inc | Andrews R. Robbins | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 915,000 | 915,000 | - | - | Stock Option (Right to Buy) | |
| Mannatech Inc | Kevin Andrew Robbins | Director | Grant, award, or other acquisition of securities at price $ 14.89 per share. | 02 Jan 2025 | 2,686 | 21,443 (0%) | 0% | 14.9 | 39,995 | Common Stock Par Value $0.0001 Per Share |
| Tamboran Resources Corp. | Andrew Robb | Director | Purchase of securities on an exchange or from another person at price $ 24.00 per share. | 28 Jun 2024 | 2,000 | 2,000 | - | 24 | 48,000 | Common Stock |
| Mannatech Inc | Kevin Andrew Robbins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 5,000 | 15,000 | - | - | Right to Purchase Common Stock | |
| 1stdibs.com Inc | Andrew Robb | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2024 | 28,533 | 0 | - | - | Restricted Stock Units | |
| 1stdibs.com Inc | Andrew Robb | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2024 | 28,533 | 43,238 | - | - | Common Stock | |
| 1stdibs.com Inc | Andrew Robb | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2024 | 31,380 | 31,380 | - | - | Restricted Stock Units | |
| 1stdibs.com Inc | Andrew Robb | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2024 | 31,380 | 31,380 | - | - | Restricted Stock Units | |
| Cogent Biosciences Inc | Andrews R. Robbins | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 1,100,000 | 1,100,000 | - | - | Stock Option (Right to Buy) | |
| Mannatech Inc | Andrew Robbins Kevin | Director | Grant, award, or other acquisition of securities at price $ 8.11 per share. | 02 Jan 2024 | 4,932 | 18,757 (0%) | 0% | 8.1 | 39,999 | Common Stock Par Value $0.0001 Per Share |
| Harpoon Therapeutics Inc | Andrews R. Robbins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 23,000 | 23,000 | - | - | Director Stock Option (Right to Buy) | |
| 1stdibs.com Inc | Andrew Robb | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2023 | 14,705 | 14,705 | - | - | Common Stock | |
| 1stdibs.com Inc | Andrew Robb | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2023 | 14,705 | 0 | - | - | Restricted Stock Units | |
| 1stdibs.com Inc | Andrew Robb | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 28,533 | 28,533 | - | - | Restricted Stock Units | |
| Cogent Biosciences Inc | Andrews R. Robbins | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 525,000 | 525,000 | - | - | Stock Option (Right to Buy) | |
| Mannatech Inc | Kevin Andrew Robbins | Director | Grant, award, or other acquisition of securities at price $ 17.43 per share. | 03 Jan 2023 | 2,294 | 13,825 (0%) | 0% | 17.4 | 39,984 | Common Stock Par Value $0.0001 Per Share |
| Mannatech Inc | Kevin Andrew Robbins | Director | Sale of securities on an exchange or to another person at price $ 22.00 per share. | 08 Dec 2022 | 1,500 | 11,531 (0%) | 0% | 22 | 33,000 | Common Stock Par Value $0.0001 Per Share |
| Harpoon Therapeutics Inc | Andrews R. Robbins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 10,167 | 10,167 | - | - | Director Stock Option (Right to Buy) | |
| 1stdibs.com Inc | Andrew Robb | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2022 | 14,705 | 14,705 | - | - | Restricted Stock Units | |
| Mannatech Inc | Kevin Andrew Robbins | Director | Sale of securities on an exchange or to another person at price $ 36.57 per share. | 28 Mar 2022 | 1,100 | 13,031 (0%) | 0% | 36.6 | 40,227 | Common Stock Par Value $0.0001 Per Share |
| Cogent Biosciences Inc | Andrews R. Robbins | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 690,000 | 690,000 | - | - | Stock Option (Right to Buy) | |
| Mannatech Inc | Kevin Andrew Robbins | Director | Grant, award, or other acquisition of securities at price $ 39.49 per share. | 03 Jan 2022 | 1,012 | 14,131 (0%) | 0% | 39.5 | 39,964 | Common Stock Par Value $0.0001 Per Share |
| Mannatech Inc | Kevin Andrew Robbins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Aug 2021 | 5,000 | 0 | - | - | Right to Purchase Common Stock | |
| Mannatech Inc | Kevin Andrew Robbins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.28 per share. | 26 Aug 2021 | 5,000 | 13,119 (0%) | 0% | 17.3 | 86,400 | Common Stock Par Value $0.0001 Per Share |
| Mannatech Inc | Kevin Andrew Robbins | Director | Sale of securities on an exchange or to another person at price $ 32.99 per share. | 23 Aug 2021 | 1,500 | 8,119 (0%) | 0% | 33.0 | 49,485 | Common Stock Par Value $0.0001 Per Share |
| Mannatech Inc | Kevin Andrew Robbins | Director | Sale of securities on an exchange or to another person at price $ 32.24 per share. | 20 Aug 2021 | 1,000 | 9,619 (0%) | 0% | 32.2 | 32,240 | Common Stock Par Value $0.0001 Per Share |
| Mannatech Inc | Kevin Andrew Robbins | Director | Sale of securities on an exchange or to another person at price $ 30.83 per share. | 17 Aug 2021 | 2,000 | 11,130 (0%) | 0% | 30.8 | 61,660 | Common Stock Par Value $0.0001 Per Share |
| Mannatech Inc | Kevin Andrew Robbins | Director | Sale of securities on an exchange or to another person at price $ 32.00 per share. | 17 Aug 2021 | 11 | 11,119 (0%) | 0% | 32 | 352 | Common Stock Par Value $0.0001 Per Share |
| Mannatech Inc | Kevin Andrew Robbins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 5,000 | 15,000 | - | - | Right to Purchase Common Stock | |
| 1stdibs.com Inc | Andrew Robb | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 17,667 | 17,667 | - | - | Stock Option (Right to Buy) | |
| Cogent Biosciences Inc | Andrews R. Robbins | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2021 | 315,200 | 315,200 | - | - | Stock Option (Right to Buy) | |
| Mannatech Inc | Kevin Andrew Robbins | Director | Grant, award, or other acquisition of securities at price $ 18.68 per share. | 04 Jan 2021 | 1,873 | 13,130 (0%) | 0% | 18.7 | 34,988 | Common Stock Par Value $0.0001 Per Share |
| Cogent Biosciences Inc | Andrews R. Robbins | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Oct 2020 | 7,442,421 | 7,442,421 | - | - | Stock Option (Right to Buy) | |
| Mannatech Inc | Kevin Andrew Robbins | Director | Sale of securities on an exchange or to another person at price $ 16.75 per share. | 25 Sep 2020 | 1,000 | 11,257 (0%) | 0% | 16.8 | 16,750 | Common Stock Par Value $0.0001 Per Share |
| Harpoon Therapeutics Inc | Andrews R. Robbins | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2020 | 20,335 | 20,335 | - | - | Director Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges